within Pharmacolibrary.Drugs.ATC.A;

model A06AD17
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 22.7 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A06AD17</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Sodium phosphate is an osmotic laxative used primarily to cleanse the bowel prior to colonoscopy or other diagnostic procedures. The drug is used for the treatment of constipation and for bowel preparation. Its use is generally approved, but oral sodium phosphate products have been associated with rare but serious nephrotoxicity and electrolyte disturbances.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals based on general pharmacokinetic knowledge for similar orally administered phosphate salts. No specific published PK models are available for sodium phosphate with the requested granularity.</p><h4>References</h4><ol><li><p>Thomas, L, et al., &amp; Rieg, T (2019). Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 128 1–7. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2018.11.008&quot;>10.1016/j.ejps.2018.11.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30419292/&quot;>https://pubmed.ncbi.nlm.nih.gov/30419292</a></p></li><li><p>Wang, X, et al., &amp; Wetterau, JR (2022). Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models. <i>Pharmacology research &amp; perspectives</i> 10(2) e00938–None. DOI:<a href=&quot;https://doi.org/10.1002/prp2.938&quot;>10.1002/prp2.938</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35194979/&quot;>https://pubmed.ncbi.nlm.nih.gov/35194979</a></p></li><li><p> (2019). Plenvu - a low-volume PEG-based colonoscopy preparation. <i>The Medical letter on drugs and therapeutics</i> 61(1564) 11–14. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30856159/&quot;>https://pubmed.ncbi.nlm.nih.gov/30856159</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A06AD17;
